| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b5c7ac62800ffaf3eef10a390a9490b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_02c6106dbad670f296a8325eee6ce39d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0002 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-10 |
| filingDate |
2007-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6b34499808bd2e4b6f8d59c072a3fa2 |
| publicationDate |
2007-11-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2007134274-A2 |
| titleOfInvention |
Antibodies to urokinase- type plasminogen activator receptor(upar)bind cancer stem cells: use in diagnosis and therapy |
| abstract |
Cancer or tumor stem cells (CaSCs) express urokinase-type plasminogen activator receptor (uPAR) on their surfaces. Ligands of uPAR, in particular antibodies are used to bind, detect, inactivate or purge uPAR-expressing cancer stem cells. Such antibodies or other ligands are also used in methods for diagnosing and treating cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2021236666-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013167130-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010028820-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9103819-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10994032-B2 |
| priorityDate |
2006-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |